Immunomic TherapeuticsImmunomic Therapeutics
Immunomic TherapeuticsImmunomic Therapeutics
  • Pipeline
  • Partnerships
  • Clinical Trials
    • ITI-1000: Glioblastoma Multiforme
    • ITI-1001: Glioblastoma Multiforme
    • ITI-3000: Merkel Cell Carcinoma
  • Team
  • Careers
  • Media
  • Contact Us
  • Pipeline
  • Partnerships
  • Clinical Trials
    • ITI-1000: Glioblastoma Multiforme
    • ITI-1001: Glioblastoma Multiforme
    • ITI-3000: Merkel Cell Carcinoma
  • Team
  • Careers
  • Media
  • Contact Us

Blog

  • Articles
  • Blog
  • Events
  • Featured
  • Highlights
  • Posters
  • Press
  • Press Releases
  • Uncategorized

ASCO Annual Meeting, June 1-5 2018

by Sara Solt in Events, Past Events
ASCO Annual Meeting, June 1-5, 2018 McCormick Place, Chicago, IL https://am.asco.org/
Read More

BioHealth Capital Region Forum, April 24-25, 2018

by Sara Solt in Events, Past Events
This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, VirginiaBio, Inova, Children’s National Health System, QIAGEN, Maryland Tech Council, University System of Maryland ...
Read More

AACR Annual Meeting, April 14-18, 2018

by Sara Solt in Events, Past Events
AACR Annual Meeting 2018 Driving Innovative Cancer Science to Patient Care  April 14-18, 2018 McCormick Place North/South Chicago, Illinois http://2018-aacr.org/
Read More

World Vaccine Congress, April 3-5, 2018

by Sara Solt in Events, Past Events
Research, Development And Strategic Partnering For The Global Vaccine Industry 2-5 April 2018, Renaissance Washington DC Downtown Hotel http://www.terrapinn.com/Conference/world-vaccine-congress-washington/index.stm  
Read More

The Fight Against Cancer Is Increasingly Personal

by Sara Solt in Articles, Highlights, Press
Scientific American custom media and Immunomic Therapeutics released an article titled, “The Fight Against Cancer is Increasingly Personal,” by reclassifying tumors, scientists are finding a path to genuine cancer cures. ...
Read More

Immunomic to Participate at 2018 BIO CEO & Investor Conference with Presentation and Panel Discussion

by Sara Solt in Press
Immuno-Oncology Panel led by Scientific American February 12, 2018 07:30 AM Eastern Standard Time   ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics (ITI), pioneering the study of investigational LAMP-based nucleic acid immunotherapy programs, ...
Read More

ITI Senior Director of Corporate Development to Present on LAMP-Vax Investigational Technology at Immuno-Oncology Frontiers World

by Sara Solt in Press, Press Releases
January 23, 2018 11:24 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Tomorrow, Immunomic Therapeutics, Inc. Senior Director of Corporate Development Sia Anagnostou will present at Phacilitate’s Immuno-Oncology Frontiers World in Miami. ...
Read More

Immunomic Therapeutics Welcomes Key Thought Leader in Immuno-Oncology, Dr. Drew Pardoll, to Its Scientific Advisory Board

by Sara Solt in Featured, Highlights, Press Releases
December 13, 2017 07:30 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, is pleased to welcome Drew Pardoll, MD, Ph.D., Director of ...
Read More

Dr. Duane Mitchell Reports Findings of Study Aimed at Aggressive Brain Cancer

by Sara Solt in Highlights, Press Releases
Cancer Vaccination Approach Incorporates Immunomic Therapeutics' LAMP-Vax Technology with CMV Technology November 22, 2017 07:30 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Last week results from a study conducted by investigators ...
Read More

Immunomic Scientist Dr. Pratima Sinha to Speak at the International Conference on Vaccine Research and Development

by Sara Solt in Press, Press Releases
Presentation to Examine the Potential of LAMP Enhancing Antitumor Immunity November 13, 2017 07:30 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Tomorrow, Immunomic Therapeutics, Inc. scientist, Dr. Pratima Sinha, will present ...
Read More

Md. is developing the next generation of life-saving vaccines

by Sara Solt in Articles, Blog, Press
Sia Anagnostou, Senior Director at Immunomic Therapeutics authored this article, "Md. is developing the next generation of life-saving vaccines" in the Baltimore Sun. http://www.baltimoresun.com/news/opinion/oped/bs-ed-op-1020-vaccines-md-20171018-story.html  
Read More

SAB Member Dr. John Sampson Named to National Academy of Medicine

by Sara Solt in Featured
Congratulations to our scientific advisory board member, Dr. John Sampson, for being named to the National Academy of Medicine http://www.dukecancerinstitute.org/news/sampson-named-national-academy-medicine
Read More
1
2345678910111213141516
…1718192021…
22232425
26
← Previous pageNext page →

Content
  • Pipeline
  • Partnerships
  • Team
  • Media
  • Contact Us
Careers
  • Careers
  • Compensation & Benefits
  • Culture & Beliefs
Policies
  • Expanded Access Policy
  • Privacy Policy
Social
  • Facebook
  • X / Twitter
  • Youtube
Telephone

+1.301.968.3501

Address

15010 Broschart Road

Rockville, MD 20850

© 2020 Immunomic Therapeutics, Inc. All Rights Reserved.